Blandine Baratte

9PUBLICATIONS
40CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsNatural products and bioactive compoundsMolecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 27, 2025
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba

|Jun 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Lhana Tisseur, Cédric Logé, Sandrine Cojean

|Dec 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama

|Nov 27, 2024
Novel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation.

Nathan Broudic, Alexandra Pacheco-Benichou, Cécile Corbière

|Oct 25, 2024
New Fusarochromanone Derivatives from the Marine Fungus Fusarium equiseti UBOCC-A-117302.

Giang Nam Pham, Béatrice Josselin, Arnaud Cousseau

|Oct 14, 2022
Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases.

Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna

Pageof 2

Frequent Collaborators

9 joint publications

Stéphane Bach

4 joint publications

Pascal Marchand

3 joint publications

Cédric Logé

3 joint publications

Marc-Antoine Bazin